These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27879042)

  • 21. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
    Prasertpetmanee S; Mahachai V; Vilaichone RK
    Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levofloxacin resistance of Helicobacter pylori strains isolated from patients in southern Poland, between 2006-2012.
    Karczewska E; Klesiewicz K; Wojtas-Bonior I; Skiba I; Sito E; Czajecki K; Zwolińska-Wcisło M; Budak A
    Acta Pol Pharm; 2014; 71(3):477-83. PubMed ID: 25265828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
    Sugimoto M; Uotani T; Sahara S; Ichikawa H; Yamade M; Sugimoto K; Furuta T
    Helicobacter; 2014 Aug; 19(4):312-8. PubMed ID: 24690010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
    Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
    Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.
    Saracino IM; Zullo A; Holton J; Castelli V; Fiorini G; Zaccaro C; Ridola L; Ricci C; Gatta L; Vaira D
    J Gastrointestin Liver Dis; 2012 Dec; 21(4):363-5. PubMed ID: 23256118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
    Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
    Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori antibiotic susceptibility patterns in Bangladesh: Emerging levofloxacin resistance.
    Aftab H; Miftahussurur M; Subsomwong P; Ahmed F; Khan AK; Yamaoka Y
    J Infect Dev Ctries; 2016 Mar; 10(3):245-53. PubMed ID: 27031456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
    Antos D; Schneider-Brachert W; Bästlein E; Hänel C; Haferland C; Buchner M; Meier E; Trump F; Stolte M; Lehn N; Bayerdörffer E
    Helicobacter; 2006 Feb; 11(1):39-45. PubMed ID: 16423088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of Helicobacter pylori in children in Vietnam in relation to antibiotic resistance.
    Nguyen TV; Bengtsson C; Yin L; Nguyen GK; Hoang TT; Phung DC; Sörberg M; Granström M
    Helicobacter; 2012 Aug; 17(4):319-25. PubMed ID: 22759333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial.
    Romano M; Cuomo A; Gravina AG; Miranda A; Iovene MR; Tiso A; Sica M; Rocco A; Salerno R; Marmo R; Federico A; Nardone G
    Gut; 2010 Nov; 59(11):1465-70. PubMed ID: 20947881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Helicobacter pylori - 2012].
    Buzás GM
    Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High rate of levofloxacin resistance in a background of clarithromycin- and metronidazole-resistant Helicobacter pylori in Vietnam.
    Phan TN; Santona A; Tran VH; Tran TN; Le VA; Cappuccinelli P; Rubino S; Paglietti B
    Int J Antimicrob Agents; 2015 Mar; 45(3):244-8. PubMed ID: 25499186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in Beijing: a prospective serial study.
    Zhang YX; Zhou LY; Song ZQ; Zhang JZ; He LH; Ding Y
    World J Gastroenterol; 2015 Mar; 21(9):2786-92. PubMed ID: 25759550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
    Lee H; Hong SN; Min BH; Lee JH; Rhee PL; Lee YC; Kim JJ
    Dig Liver Dis; 2015 Feb; 47(2):114-8. PubMed ID: 25467826
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
    Matsushima M; Suzuki T; Kurumada T; Watanabe S; Watanabe K; Kobayashi K; Deguchi R; Masui A; Takagi A; Shirai T; Muraoka H; Kobayashi I; Mine T
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):232-6. PubMed ID: 16460479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.
    Kwon YH; Kim N; Lee JY; Choi YJ; Yoon K; Nam RH; Suh JH; Lee JW; Lee DH
    Scand J Gastroenterol; 2016 Mar; 51(3):270-6. PubMed ID: 26452405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens].
    Cheng H; Hu FL; Li J
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2679-82. PubMed ID: 17199976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole.
    Marzio L; Coraggio D; Capodicasa S; Grossi L; Cappello G
    Helicobacter; 2006 Aug; 11(4):237-42. PubMed ID: 16882326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.